azathioprine has been researched along with pulmicort in 80 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 7 (8.75) | 18.2507 |
2000's | 32 (40.00) | 29.6817 |
2010's | 37 (46.25) | 24.3611 |
2020's | 4 (5.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Andus, T; Gross, V; Schölmerich, J | 1 |
Manns, MP; Rambusch, EG | 1 |
Tytgat, GN; van Deventer, SJ | 1 |
Breslin, NP; Sutherland, LR | 1 |
Audeguy, P; Signoret, C | 1 |
Lowry, PW; Sandborn, WJ | 1 |
Hüppe, D; Schenck, B; Tromm, A | 1 |
Czaja, AJ; Lindor, KD | 1 |
Van Gossum, A | 1 |
Evans, DF; Kumar, D; Nugent, SG; Rampton, DS | 1 |
Rutgeerts, PJ | 1 |
Lichtenstein, GR | 1 |
Farthing, MJ | 1 |
Niemelä, S | 1 |
Czaja, AJ | 2 |
Castro Fernández, M; Galán Jurado, V; García Díaz, E; Rodríguez Alonso, C; Romero, M | 1 |
Schölmerich, J | 1 |
Fleig, WE | 1 |
Göke, B; Ochsenkühn, T; Sackmann, M | 1 |
Buller, H; Levine, A; Markowitz, J; Milo, T | 1 |
Kullak-Ublick, GA; Rammert, Ch | 1 |
Beglinger, Ch | 1 |
Blickstein, I; Kruchkovich, J | 1 |
Bruninga, K; Jakate, S; Kaplan, M; Keshavarzian, A; Losurdo, J; Mutlu, EA | 1 |
Herrlinger, K; Stange, EF | 1 |
Kruis, W | 1 |
Büning, C; Lochs, H | 1 |
Lakatos, L; Lakatos, PL | 1 |
Bhagat, G; Brar, P; Egbuna, I; Green, PH; Lee, S; Lewis, S | 1 |
Detsky, A; Kennedy, ED; Llewellyn-Thomas, HA; McLeod, RS; Steinhart, AH; To, T | 1 |
Christidou, A; Koilakou, S; Mantzaris, GJ; Petraki, K; Polyzou, P; Roussos, A; Sfakianakis, M | 1 |
Arrighi, HM; Hass, S; Marehbian, J; Sandborn, WJ; Tian, H | 1 |
Avinash, B; Chacko, A; Dutta, AK | 1 |
Bischoff, A | 1 |
Bush, A; Saglani, S | 1 |
Strassburg, CP | 1 |
Gil, H; Lohse, AW | 1 |
Mayo, MJ | 1 |
Blumenstein, I; Bock, H; Dignass, A; Filmann, N; Hartmann, F; Herrmann, E; Schröder, O; Stein, J; Tacke, W; Zeuzem, S; Zosel, C | 1 |
Blonski, W; Buchner, AM; Lichtenstein, GR | 1 |
Potter, TG; Snider, KR | 1 |
Cheon, JH; Choi, CH; Jang, BI; Kim, YH; Lee, H; Lee, KM; Shin, SJ; Yang, SK; Ye, BD | 1 |
Basevitz, A; Duek, G; Malnick, S; Melzer, E | 1 |
Ascolani, M; Biancone, L; Boirivant, M; Cossu, A; Pallone, F | 1 |
Baruch, Y; Koletzko, S; Manns, MP; Melter, M; Nemeth, A; Pröls, M; Rodeck, B; Strassburg, CP; Woynarowski, M; Woźniak, M | 1 |
Delgado, B; Delgado, JS; Fich, A; Kriger, O; Malnick, S; Melzer, E; Menachem, Y; Novack, V; Rosenthal, A; Vodonos, A; Wilkof-Segev, R | 1 |
Mieli-Vergani, G; Vergani, D | 1 |
Cottone, M; Orlando, A; Renna, S | 1 |
Bach, H; Bressler, B; Grist, J; Silverberg, MS; Stempak, JM; Xia, A | 1 |
Rogler, G; Scharl, M; Schoepfer, AM; Vavricka, SR | 1 |
Cinotti, E; De Cassan, C; Savarino, E | 1 |
Eriksson, AS; Gerdin, L; Myrelid, P; Olaison, G; Sjödahl, R; Söderholm, JD; Ström, M | 1 |
Chande, N; Feagan, BG; Marshall, JK; Nelson, S; Parker, CE; Sandborn, WJ; Seow, CH | 1 |
Mohammad, S | 1 |
Stiefelhagen, P | 1 |
Elliott, TR; Macrae, FA; Miller, C | 1 |
Phaw, NA; Tsai, HH | 1 |
Andrade, RJ; Bouma, G; Dalekos, GN; de Boer, YS; Floreani, A; Gleeson, D; Heneghan, MA; Hirschfield, GM; Invernizzi, P; Lenzi, M; Liberal, R; Lohse, AW; Macedo, G; Milkiewicz, P; Terziroli, B; van Hoek, B; Vierling, JM | 1 |
Arguedas, Y; Busquets, D; Casanova, MJ; Fernandez-Bañares, F; Fernández-Salazar, L; Gisbert, JP; Guagnozzi, D; Lucendo, AJ; Pérez-Aisa, A; Piqueras, M; Robles, V; Ruiz-Cerulla, A | 1 |
Jaeckel, E; Manns, MP; Taubert, R | 1 |
Guerra Romero, A; López Serrano, P; Pérez Calle, JL | 1 |
Afif, W; Bernstein, CN; Bitton, A; Borgaonkar, M; Bressler, B; Chauhan, U; Halloran, B; Jones, J; Kennedy, E; Khanna, R; Leontiadis, GI; Loftus, EV; Marshall, JK; Meddings, J; Moayyedi, P; Murthy, S; Panaccione, R; Plamondon, S; Rosenfeld, G; Schwartz, D; Seow, CH; Steinhart, AH; Targownik, L; Williams, C | 1 |
Binicier, OB; Günay, S | 1 |
Booth, AT; Curran, T; Forster, E; George, V | 1 |
Ardizzone, S; Bezzio, C; Bosani, M; Carmagnola, S; Cassinotti, A; Chibbar, R; Dell'Era, A; Grillo, S; Landi, S; Maconi, G; Massari, A; Mezzina, N; Molteni, P; Pastorelli, L | 1 |
Casanova, MJ; Gisbert, JP; Rojo, E | 1 |
Arieira, C; Cotter, J; Cúrdia Gonçalves, T; Dias de Castro, F; Firmino-Machado, J; Freitas, M; Lima Capela, T; Macedo Silva, V; Moreira, MJ | 1 |
Lohse, AW; Steinmann, S | 1 |
Becker, B; Bernsmeier, C; Böhm, S; Braegger, C; Bresson-Hadni, S; Cerny, A; Cremer, M; De Gottardi, A; Di Bartolomeo, C; Filipowicz Sinnreich, M; Furlano, R; Galante, A; Heyland, K; Kremer, AE; Limoni, C; Ludz, C; McLin, V; Mertens, J; Mieli-Vergani, G; Müller, P; Nydegger, A; Posovszky, C; Righini-Grunder, F; Rock, N; Semela, D; Sokollik, C; Stirnimann, G; Terziroli Beretta-Piccoli, B; Vergani, D | 1 |
29 review(s) available for azathioprine and pulmicort
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Crohn disease: prevention and drug therapy].
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Immunosuppressive Agents; Mesalamine; Pregnenediones; Recurrence | 1995 |
[Therapy of autoimmune hepatitis].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Autoimmune Diseases; Azathioprine; Budesonide; Cyclosporins; Diagnosis, Differential; Drug Therapy, Combination; Female; Hepatitis; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Prednisolone; Pregnenediones; Prognosis; Tacrolimus; Time Factors | 1996 |
[Drug treatment of Crohn's disease].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Protocols; Crohn Disease; Cyclosporine; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Mesalamine; Methotrexate; Prednisone; Remission Induction; Treatment Outcome | 1998 |
The case against routine post-operative therapy for prevention of recurrence in Crohn's disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Digestive System Surgical Procedures; Humans; Mesalamine; Metronidazole; Postoperative Period; Prognosis; Randomized Controlled Trials as Topic; Secondary Prevention | 1998 |
Intestinal luminal pH in inflammatory bowel disease: possible determinants and implications for therapy with aminosalicylates and other drugs.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Biological Availability; Budesonide; Catheterization; Electrodes; Humans; Hydrogen-Ion Concentration; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Reference Values; Telemetry | 2001 |
Conventional treatment of Crohn's disease: objectives and outcomes.
Topics: Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Methotrexate; Prednisone; Quality of Life; Recurrence; Sulfasalazine; Treatment Outcome | 2001 |
Approach to corticosteroid-dependent and corticosteroid-refractory Crohn's disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Cyclosporine; Etanercept; Female; Gastrointestinal Agents; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Methotrexate; Receptors, Tumor Necrosis Factor; Thalidomide; Treatment Outcome | 2001 |
[Drug therapy of Crohn disease].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Crohn Disease; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Secondary Prevention; Treatment Outcome | 2001 |
Treatment strategies in autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Clinical Trials as Topic; Cyclosporine; Disease Progression; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Prednisolone; Tacrolimus; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
[Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Crohn Disease; Cyclosporins; Diagnosis, Differential; Gastrointestinal Agents; Humans; Ileostomy; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Meta-Analysis as Topic; Methotrexate; Parenteral Nutrition; Prednisolone; Quality of Life; Time Factors; Ultrasonography | 2003 |
[Management of ulcerative colitis].
Topics: Administration, Oral; Adrenal Cortex Hormones; Aminosalicylic Acids; Anemia; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antiviral Agents; Azathioprine; Budesonide; Clinical Trials as Topic; Colectomy; Colitis, Ulcerative; Colonic Pouches; Colonoscopy; Colorectal Neoplasms; Cyclosporins; Gastrointestinal Agents; Humans; Hydrocortisone; Immunosuppressive Agents; Infliximab; Injections, Intravenous; Interferons; Mercaptopurine; Mesalamine; Osteoporosis; Placebos; Practice Guidelines as Topic; Recurrence; Remission Induction; Risk Factors; Suppositories; Time Factors | 2003 |
[Treatment of Crohn's disease].
Topics: Acute Disease; Adjuvants, Immunologic; Adrenal Cortex Hormones; Algorithms; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Case-Control Studies; Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Metronidazole; Osteoporosis; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Time Factors | 2003 |
[Chronic inflammatory bowel diseases].
Topics: Adrenal Cortex Hormones; Adult; Aminosalicylic Acids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Colonoscopy; Controlled Clinical Trials as Topic; Crohn Disease; Diagnosis, Differential; Female; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Magnetic Resonance Imaging; Mercaptopurine; Methotrexate; Metronidazole; Pouchitis; Remission Induction; Tacrolimus; Time Factors; Tomography, X-Ray Computed; Ultrasonography | 2004 |
[Crohn's disease--standards of treatment 2004].
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Algorithms; Aminosalicylic Acids; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Mercaptopurine; Methotrexate; Mycophenolic Acid; Practice Guidelines as Topic; Prognosis; Remission Induction; Risk Factors; Time Factors | 2005 |
Conventional therapy for Crohn's disease.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Crohn Disease; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Nutrition Therapy; Randomized Controlled Trials as Topic; Remission Induction | 2006 |
[Medical therapy of inflammatory bowel diseases: Crohn's disease].
Topics: Acute Disease; Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Chronic Disease; Crohn Disease; Fistula; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mesalamine; Methotrexate; Severity of Illness Index | 2007 |
[For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
Topics: Adolescent; Adult; Age Factors; Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Child; Colitis, Ulcerative; Colorectal Neoplasms; Crohn Disease; Enteral Nutrition; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Mesalamine; Meta-Analysis as Topic; Middle Aged; Prednisone; Pregnancy; Randomized Controlled Trials as Topic; Risk Factors | 2009 |
Management of severe asthma in children.
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Allergens; Anti-Asthmatic Agents; Asthma; Azathioprine; Bronchial Provocation Tests; Bronchodilator Agents; Budesonide; Budesonide, Formoterol Fumarate Drug Combination; Child; Clinical Trials as Topic; Comorbidity; Cyclosporine; Drug Combinations; Drug Resistance, Multiple; Drug Therapy, Combination; Eosinophils; Ethanolamines; Formoterol Fumarate; House Calls; Humans; Immunoglobulin E; Interdisciplinary Communication; Methotrexate; Off-Label Use; Risk Factors; Severity of Illness Index; Spirometry; Terbutaline; Tobacco Smoke Pollution; Tomography, X-Ray Computed; Treatment Outcome | 2010 |
Autoimmune hepatitis.
Topics: Animals; Azathioprine; Budesonide; Diagnosis, Differential; Drug Therapy, Combination; Genetic Predisposition to Disease; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Major Histocompatibility Complex; Polyendocrinopathies, Autoimmune; Prednisone; Prognosis; Recurrence | 2010 |
Management of autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Drug Hypersensitivity; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Purine-Pyrimidine Metabolism, Inborn Errors; Tacrolimus | 2011 |
Inflammatory bowel disease therapy: current state-of-the-art.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Budesonide; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Infliximab; Mercaptopurine; Natalizumab | 2011 |
Budesonide for the treatment of autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Drug Labeling; Glucocorticoids; Hepatitis, Autoimmune; Humans; Prednisone | 2011 |
The treatment of autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Cyclosporine; Hepatitis, Autoimmune; Humans; Mycophenolic Acid | 2012 |
Comparing medical treatments for Crohn's disease.
Topics: Adrenal Cortex Hormones; Aminosalicylic Acids; Anti-Bacterial Agents; Azathioprine; Biological Factors; Budesonide; Crohn Disease; Humans; Intestinal Fistula; Methotrexate; Probiotics; Randomized Controlled Trials as Topic; Secondary Prevention | 2013 |
Steroid use in Crohn's disease.
Topics: Adrenal Cortex Hormones; Azathioprine; Budesonide; Clinical Trials as Topic; Crohn Disease; Humans; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha | 2014 |
Current and prospective pharmacotherapy for autoimmune hepatitis.
Topics: Adrenal Cortex Hormones; Animals; Antibodies, Monoclonal, Murine-Derived; Azathioprine; Budesonide; Hepatitis, Autoimmune; Humans; Immunologic Factors; Immunosuppressive Agents; Liver; Mycophenolic Acid; Rituximab; Salvage Therapy; Sirolimus | 2014 |
New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
Topics: Anti-Inflammatory Agents; Azathioprine; Budesonide; Colitis, Ulcerative; Congresses as Topic; Crohn Disease; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Maintenance Chemotherapy; Mesalamine; Methotrexate; Review Literature as Topic; Secondary Prevention | 2015 |
Treatment of microscopic colitis: the role of budesonide and new alternatives for refractory patients.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antidiarrheals; Antimetabolites; Azathioprine; Biological Products; Budesonide; Colitis, Collagenous; Colitis, Lymphocytic; Colitis, Microscopic; Diarrhea; Humans; Loperamide; Malabsorption Syndromes; Mesalamine; Methotrexate; Prednisolone; Quality of Life; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Time Factors | 2020 |
5 trial(s) available for azathioprine and pulmicort
Article | Year |
---|---|
Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Azathioprine; Bone Density; Budesonide; Female; Femur; Hepatitis, Autoimmune; Humans; Male; Middle Aged; Pilot Projects; Prednisone; Retreatment; Spine; Treatment Failure; Ursodeoxycholic Acid | 2000 |
Budesonide in the treatment of refractory celiac disease.
Topics: Adult; Aged; Azathioprine; Budesonide; Celiac Disease; Combined Modality Therapy; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Middle Aged; Treatment Outcome | 2007 |
Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
Topics: Adult; Azathioprine; Budesonide; Crohn Disease; Dose-Response Relationship, Drug; Drug Resistance; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Intestinal Mucosa; Male; Middle Aged; Prospective Studies; Remission Induction; Single-Blind Method; Treatment Outcome; Young Adult | 2009 |
Budesonide versus prednisone with azathioprine for the treatment of autoimmune hepatitis in children and adolescents.
Topics: Adolescent; Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Budesonide; Child; Child, Preschool; Double-Blind Method; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Prednisone; Prospective Studies; Remission Induction; Treatment Outcome | 2013 |
The Swedish Crohn Trial: A Prematurely Terminated Randomized Controlled Trial of Thiopurines or Open Surgery for Primary Treatment of Ileocaecal Crohn's Disease.
Topics: Adult; Age Factors; Anastomosis, Surgical; Area Under Curve; Azathioprine; Budesonide; Cecum; Colectomy; Crohn Disease; Female; Follow-Up Studies; Humans; Ileum; Laparotomy; Male; Middle Aged; Prospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Statistics, Nonparametric; Sweden; Treatment Failure; Treatment Outcome; Young Adult | 2016 |
46 other study(ies) available for azathioprine and pulmicort
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Autoimmune hepatitis: importance of budesonide in intolerance to prednisolone].
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Azathioprine; Budesonide; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Liver Function Tests; Prednisolone | 1999 |
A comparison of budesonide and mesalamine for active Crohn's disease.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Dose-Response Relationship, Drug; Double-Blind Method; Humans; Immunosuppressive Agents; Mesalamine; Multicenter Studies as Topic; Prednisolone; Remission Induction | 1999 |
[Extra-intestinal manifestations and complications in chronic active ulcerative colitis in childhood and adolescence].
Topics: Adolescent; Azathioprine; Budesonide; Child; Colitis, Ulcerative; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Hydrocortisone; Leg Ulcer; Male; Mesalamine; Prednisolone; Pyoderma Gangrenosum; Treatment Outcome | 1999 |
[Therapy of chronic inflammatory intestinal disease].
Topics: Acute Disease; Anti-Inflammatory Agents; Antibodies, Monoclonal; Azathioprine; Budesonide; Chronic Disease; Colectomy; Colitis, Ulcerative; Crohn Disease; Cyclosporine; Drug Combinations; Gastrointestinal Agents; Glucosamine; Humans; Immunosuppressive Agents; Infliximab; Sulfasalazine | 2000 |
Ileal Crohn's disease is best treated by surgery.
Topics: Azathioprine; Budesonide; Crohn Disease; Glucocorticoids; Humans; Ileum; Mesalamine; Prednisolone | 2002 |
[Treatment of steroid-refractory ulcerative colitis with infliximab].
Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Blood Transfusion; Budesonide; Colitis, Ulcerative; Drug Resistance; Drug Therapy, Combination; Enteral Nutrition; Female; Gastrointestinal Hemorrhage; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methylprednisolone; Prednisone; Remission Induction; Tumor Necrosis Factor-alpha | 2003 |
[Acute episode].
Topics: Acute Disease; Adult; Age Factors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Child; Controlled Clinical Trials as Topic; Crohn Disease; Drug Therapy, Combination; Follow-Up Studies; Humans; Immunosuppressive Agents; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Nutritional Physiological Phenomena; Prednisolone; Time Factors | 2003 |
[Maintaining a remission].
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Child; Crohn Disease; Enzyme Inhibitors; Female; Folic Acid Antagonists; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Meta-Analysis as Topic; Methotrexate; Placebos; Postoperative Care; Prednisolone; Pregnancy; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence; Remission Induction; Risk Factors; Time Factors | 2003 |
Consensus and controversy in the management of pediatric Crohn disease: an international survey.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Attitude of Health Personnel; Azathioprine; Bone Density; Budesonide; Consensus; Crohn Disease; Gastroenterology; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Pediatrics; Practice Guidelines as Topic; Surveys and Questionnaires | 2003 |
[Autoimmune hepatitis during pregnancy].
Topics: Adult; Autoantibodies; Azathioprine; Budesonide; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Infant, Newborn; Male; Obstetric Labor Complications; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Ursodeoxycholic Acid | 2003 |
Endoscopy in eosinophilic esophagitis: "feline" esophagus and perforation risk.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Biomarkers; Biopsy; Budesonide; Catheterization; Deglutition Disorders; Diagnosis, Differential; Dilatation, Pathologic; Endoscopy, Digestive System; Eosinophilia; Eosinophils; Esophageal Perforation; Esophagitis; Esophagus; Female; Follow-Up Studies; Gastric Mucosa; Gastroesophageal Reflux; Gastrointestinal Motility; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Immunosuppressive Agents; Male; Prednisone; Proton Pump Inhibitors; Proton Pumps; Recurrence; Risk Factors; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
[New research results give hope. Causal therapy of Crohn disease in sight].
Topics: Algorithms; Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Crohn Disease; Defensins; Humans; Immunosuppressive Agents; Mesalamine; Prednisolone; Prognosis; Time Factors; Trichuris | 2004 |
Do patients consider postoperative maintenance therapy for Crohn's disease worthwhile?
Topics: Adult; Aged; Azathioprine; Budesonide; Canada; Crohn Disease; Cross-Sectional Studies; Decision Support Techniques; Fees, Pharmaceutical; Female; Fish Oils; Focus Groups; Gastrointestinal Agents; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Patient Satisfaction; Postoperative Care; Regression Analysis; Reproducibility of Results; Secondary Prevention | 2008 |
Adverse events associated with common therapy regimens for moderate-to-severe Crohn's disease.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Budesonide; Case-Control Studies; Comorbidity; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Longitudinal Studies; Male; Mercaptopurine; Methotrexate; Middle Aged; Outcome Assessment, Health Care; Prednisone; Prevalence; Proportional Hazards Models; Steroids; United States | 2009 |
Pediatric inflammatory bowel disease in South India.
Topics: Adolescent; Anti-Inflammatory Agents; Antineoplastic Agents; Azathioprine; Budesonide; Catchment Area, Health; Child; Child, Preschool; Drug Combinations; Drug Therapy, Combination; Female; Humans; India; Infant; Inflammatory Bowel Diseases; Male; Methotrexate; Prednisolone; Prevalence | 2009 |
[Drug therapy of Crohn's disease: slowly increase or start aggressively right away?].
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Clinical Trials as Topic; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Mesalamine; Methotrexate; Practice Guidelines as Topic; Prednisolone; Remission Induction | 2010 |
Reactivation of autoimmune hepatitis during budesonide monotherapy, and response to standard treatment.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Azathioprine; Budesonide; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Prednisolone; Recurrence; Young Adult | 2011 |
Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Budesonide; Colitis, Ulcerative; Crohn Disease; Cross-Sectional Studies; Cyclosporine; Female; Germany; Humans; Immunosuppressive Agents; Infliximab; Male; Mercaptopurine; Mesalamine; Methotrexate; Middle Aged; Practice Patterns, Physicians'; Prospective Studies; Remission Induction; Severity of Illness Index; Sex Factors; Tacrolimus | 2011 |
[Guidelines for the management of Crohn's disease].
Topics: Anti-Inflammatory Agents; Antibodies, Monoclonal; Antimetabolites, Antineoplastic; Budesonide; Crohn Disease; Databases, Factual; Female; Fistula; Humans; Infliximab; Intestinal Perforation; Male; Mercaptopurine; Mesalamine; Methotrexate; Prednisolone; Pregnancy; Recurrence; Risk Factors; Severity of Illness Index; Sulfasalazine | 2012 |
"In vitro" azathioprine-induced changes in peripheral T cell apoptosis and IFN-γ production associate with drug response in patients with Crohn's Disease.
Topics: Adalimumab; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Azathioprine; Budesonide; Cells, Cultured; Crohn Disease; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infliximab; Interferon-gamma; Interleukin-10; Male; Mesalamine; Middle Aged; Retrospective Studies; T-Lymphocytes; Tumor Necrosis Factor-alpha; Young Adult | 2013 |
Autoimmune hepatitis in southern Israel: a 15-year multicenter study.
Topics: Adult; Azathioprine; Biopsy; Budesonide; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Incidence; Israel; Liver; Male; Middle Aged; Prednisone; Prevalence; Prognosis; Retrospective Studies; Treatment Outcome | 2013 |
Budesonide for juvenile autoimmune hepatitis? Not yet.
Topics: Azathioprine; Budesonide; Female; Hepatitis, Autoimmune; Humans; Male; Prednisone | 2013 |
Effect of inflammatory bowel disease therapies on immunogenicity of Mycobacterium paratuberculosis proteins.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Bacterial; Antibodies, Monoclonal; Azathioprine; Bacterial Proteins; Budesonide; Case-Control Studies; Colitis, Ulcerative; Crohn Disease; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infliximab; Male; Mesalamine; Middle Aged; Mycobacterium avium subsp. paratuberculosis; Prednisone; Protein Tyrosine Phosphatases; Young Adult | 2014 |
An unusual cutaneous manifestation in a patient with cystic fibrosis.
Topics: Anti-Inflammatory Agents; Azathioprine; Biopsy; Budesonide; Colonoscopy; Crohn Disease; Cystic Fibrosis; Drug Therapy, Combination; Female; Gastrointestinal Agents; Humans; Skin Diseases; Time Factors; Treatment Outcome; Young Adult | 2014 |
Budesonide as first-line therapy for non-cirrhotic autoimmune hepatitis in children: a decision analysis.
Topics: Adolescent; Anti-Inflammatory Agents; Budesonide; Child; Child, Preschool; Decision Support Techniques; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Health Care Costs; Hepatitis, Autoimmune; Humans; Illinois; Markov Chains; Mercaptopurine; Monte Carlo Method; Prednisone; Quality-Adjusted Life Years; Treatment Outcome | 2016 |
[Not a cure, but a normal life].
Topics: Azathioprine; Biological Products; Budesonide; Cell Adhesion Molecules; Drug Therapy, Combination; Humans; Inflammatory Bowel Diseases; Mesalamine; Tumor Necrosis Factor-alpha | 2016 |
Severe perianal shingles during azathioprine and budesonide treatment for Crohn's disease-preventable with zoster vaccine?
Topics: Adult; Animals; Azathioprine; Budesonide; Crohn Disease; Glucocorticoids; Herpes Zoster; Herpes Zoster Vaccine; Humans; Immunosuppressive Agents; Male; Perianal Glands | 2016 |
Eosinophilic gastroenteritis: a challenge to diagnose and treat.
Topics: Acetates; Adult; Anti-Bacterial Agents; Azathioprine; Biopsy; Budesonide; Clarithromycin; Cyclopropanes; Endoscopy; Enteritis; Eosinophilia; Eosinophils; Female; Gastritis; Gastroenteritis; Humans; Leukocyte Count; Macrolides; Mucous Membrane; Quinolines; Sulfides | 2016 |
Expert clinical management of autoimmune hepatitis in the real world.
Topics: Azathioprine; Biopsy; Budesonide; Cyclosporine; Health Care Surveys; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Methyltransferases; Mycophenolic Acid; Rituximab; Tacrolimus | 2017 |
Collagenous colitis: Requirement for high-dose budesonide as maintenance treatment.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Colitis, Collagenous; Dose-Response Relationship, Drug; Female; Humans; Logistic Models; Maintenance Chemotherapy; Male; Mercaptopurine; Middle Aged; Multivariate Analysis; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Spain | 2017 |
Budesonide in Autoimmune Hepatitis: The Right Drug at the Right Time for the Right Patient.
Topics: Alanine Transaminase; Azathioprine; Budesonide; Hepatitis, Autoimmune; Humans | 2018 |
Azathioprine-induce acute submandibular sialadenitis in a patient with Crohn's disease.
Topics: Acute Disease; Adult; Azathioprine; Budesonide; Crohn Disease; Drug Substitution; Humans; Immunosuppressive Agents; Male; Mercaptopurine; Sialadenitis; Submandibular Gland; Ultrasonography | 2018 |
Canadian Association of Gastroenterology Clinical Practice Guideline for the Management of Luminal Crohn's Disease.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Azathioprine; Budesonide; Canada; Crohn Disease; Gastroenterology; Gastrointestinal Agents; Glucocorticoids; Humans; Immunosuppressive Agents; Induction Chemotherapy; Maintenance Chemotherapy; Mesalamine; Methotrexate; Prednisolone; Societies, Medical; Sulfasalazine; Treatment Outcome; Tumor Necrosis Factor Inhibitors; Ustekinumab | 2019 |
The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study.
Topics: Adult; Aged; Azathioprine; Budesonide; Drug Therapy, Combination; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Male; Middle Aged; Prednisolone; Remission Induction; Retrospective Studies; Socioeconomic Factors | 2019 |
Gastrocolic Fistula Involving the Pancreas in a Patient With Crohn's Disease.
Topics: Adalimumab; Azathioprine; Budesonide; Colectomy; Colitis; Crohn Disease; Gastric Fistula; Humans; Ileitis; Immunosuppressive Agents; Intestinal Fistula; Male; Middle Aged; Pancreatic Fistula; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis: A real-life experience.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Budesonide; Colitis, Ulcerative; Dosage Forms; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Italy; Logistic Models; Male; Mesalamine; Middle Aged; Multivariate Analysis; Retrospective Studies; Severity of Illness Index; Sulfasalazine; Treatment Outcome | 2019 |
Finding Predictors of Azathioprine-Induced Pancreatitis in Patients With Inflammatory Bowel Disease.
Topics: Azathioprine; Budesonide; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Pancreatitis; Retrospective Studies | 2022 |
Treatment of autoimmune hepatitis: Budesonide does not solve our problems.
Topics: Azathioprine; Budesonide; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Prednisone | 2023 |
Epidemiology, clinical features and management of autoimmune hepatitis in Switzerland: a retrospective and prospective cohort study.
Topics: Adolescent; Adult; Azathioprine; Budesonide; Child; Child, Preschool; Cohort Studies; Female; Hepatitis, Autoimmune; Humans; Infant; Inflammatory Bowel Diseases; Liver Cirrhosis; Liver Cirrhosis, Biliary; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Retrospective Studies; Switzerland | 2023 |